Revlimid and Indigestion - a phase IV clinical study of FDA data

Summary:

Indigestion is found among people who take Revlimid, especially for people who are female, 60+ old, have been taking the drug for < 1 month.

The phase IV clinical study analyzes which people take Revlimid and have Indigestion. It is created by eHealthMe based on reports of 281,221 people who have side effects when taking Revlimid from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.

With medical big data and AI algorithms, eHealthMe enables everyone to run phase IV clinical trial to detect adverse drug outcomes and monitor effectiveness. Our original studies have been referenced on 600+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Most recently, phase IV clinial trails for COVID 19 vaccines have been added, check here.



On Jun, 01, 2022

281,221 people reported to have side effects when taking Revlimid.
Among them, 992 people (0.35%) have Indigestion.


What is Revlimid?

Revlimid has active ingredients of lenalidomide. It is often used in multiple myeloma. eHealthMe is studying from 281,512 Revlimid users for its effectiveness, alternative drugs and more.

What is Indigestion?

Indigestion is found to be associated with 3,480 drugs and 3,092 conditions by eHealthMe.

Number of Revlimid and Indigestion reports submitted per year:

Could Revlimid cause Indigestion?

Time on Revlimid when people have Indigestion *:

Click here to view

Gender of people who have Indigestion when taking Revlimid*:

Click here to view

Age of people who have Indigestion when taking Revlimid *:

Click here to view

Common drugs people take besides Revlimid *:

Click here to view

Common side effects people have besides Indigestion *:

Click here to view

Common conditions people have *:

Click here to view

* Approximation only. Some reports may have incomplete information.

Do you take Revlimid and have Indigestion?

Check whether Indigestion is associated with a drug or a condition

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.



Related studies

Alternative drugs to, pros and cons of Revlimid:

Indigestion treatments and more:

COVID vaccines that are related to Indigestion:

How severe was Indigestion and when was it recovered:

Expand to all the drugs that have ingredients of lenalidomide:

Common drugs associated with Indigestion:

All the drugs that are associated with Indigestion:

Common conditions associated with Indigestion:

All the conditions that are associated with Indigestion:

How the study uses the data?

The study uses data from the FDA. It is based on lenalidomide (the active ingredients of Revlimid) and Revlimid (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe: